Fundz

Acrigen Biosciences, Inc. reported raising $775,000 in an initial SEC Form D filing, from an offering of $1 Million

PRIVATEJul 01, 2019$775K of $1M raised

Amount Raised

$775,000

$775,000 sold, per SEC Form D (first sale Jul 1, 2019)

Round Type

Seed

KensingtonBiotechnology

Quick answer

ACRIGEN BIOSCIENCES, INC. raised $775,000 in a Seed round, dated July 1, 2019. ACRIGEN BIOSCIENCES, INC. is based in Kensington, California, United States.

How much did ACRIGEN BIOSCIENCES, INC. raise?
ACRIGEN BIOSCIENCES, INC. raised $775,000 in a Seed round on July 1, 2019.
What does ACRIGEN BIOSCIENCES, INC. do?
Acrigen Biosciences is an early-stage life science gene editing company based in Berkeley, California.
Where is ACRIGEN BIOSCIENCES, INC. based and how big is it?
ACRIGEN BIOSCIENCES, INC. is based in Kensington, California, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as ACRIGEN BIOSCIENCES, INC. that raised within 45 days of this round, from Fundz verified event records.

  • Limelight Bio, Inc. raised $14M on August 15, 2019.
  • Xenon Ophthalmics raised $2.4M (Seed) on August 15, 2019.
  • CalciMedica raised $55M on August 15, 2019.
  • Werewolf Therapeutics raised $32M on August 15, 2019.
  • Inovio raised $15M on August 15, 2019.
  • Botanix Pharmaceuticals raised $20M on August 14, 2019.

Who to call at ACRIGEN BIOSCIENCES, INC., and when

A new round usually means ACRIGEN BIOSCIENCES, INC. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day ACRIGEN BIOSCIENCES, INC. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at ACRIGEN BIOSCIENCES, INC., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at ACRIGEN BIOSCIENCES, INC.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

ACRIGEN BIOSCIENCES, INC.

Location

202 Stanford Avenue

Kensington, California, United States

About

Acrigen Biosciences is an early-stage life science gene editing company based in Berkeley, California. We are building a pipeline of therapies to treat genetic disorders using our proprietary precision gene editing technology. Our technology utilizes novel CRISPR-Cas gene editors coupled with anti-CRISPR proteins to improve the precision, efficacy, and safety of genetic therapies. The company was co-founded in 2019 by Dr. Joseph Bondy-Denomy (Associate Professor at UCSF and discoverer of anti-CRISPR proteins) and Dr. David Rabuka (former Founder and CSO of Redwood Bioscience) with the mission of bringing precision genetic therapies to patients. For more information, go to www.acrigen.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment ACRIGEN BIOSCIENCES, INC. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for ACRIGEN BIOSCIENCES, INC.'s next move

See what Strategic adds

ACRIGEN BIOSCIENCES, INC. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.